Publiziert in: Marktpuls, Unternehmen
Frei

Invitation to the Conference Call - Medacta 2020 Preliminary unaudited top-line figures Donnerstag, 14. Januar 2021 - 16:50

eyJ0eXAiOiJKV1QiLCJhbGciOiJIUzUxMiJ9.eyJpc3MiOiJmaWxlX3N0b3JhZ2UiLCJpYXQiOjE1NjgwMjI5MDYsInRva2VuX3V1aWQiOiI3YjBjMTZiNS0zMjI2LTQ3MjYtYTUzMS0yYTQ2Mjg3YjE5OTAifQ._gMqbfmjmphB6paw2UAnOQVMphuAlajhoXwl3dw9waMRKIurLjbN8ST2sDf3uCx6RQcVPAMgcthmhPOobYU4lQ
Medacta Group SA: 2020 Preliminary unaudited top-line figures 
Dear Madam or Sir,
 
You are cordially invited to attend our conference call concerning the 2020 preliminary unaudited top-line figures of Medacta Group SA.
 
Francesco Siccardi (CEO) and Corrado Farsetta (CFO) will present the results followed by a question and answer session. The call will be held in English. Registration is not necessary.
 

Date

January 21, 2021

Time

3.00 pm (CEST)

Dial-in numbers

CH: +41445806522

DE: +4969201744220

UK: +442030092470

US: +18774230830

PIN

22523666#

 

The press release of the 2020 preliminary unaudited top-line figures as well as a corresponding presentation will be available on our company's website  https://www.medacta.com/EN/home-investors-global as of 7.00 am CET on the reporting day.

To follow the presentation, please use the below webcast link (no audio signal):  

https://www.webcast-eqs.com/medacta20210121/no-audio

The conference call can also be followed live as a webcast with audio signal and presentation via the following link:  

https://www.webcast-eqs.com/medacta20210121

We look forward to welcoming you at our conference call.

Best regards

Medacta Group SA
 
About Medacta
Medacta is an international company specialized in the design and production of innovative orthopaedic products and the development of accompanying surgical techniques for joint replacement, spine surgery, and sports medicine. Established in 1999 in Switzerland, Medacta's products and surgical techniques are characterized by innovation. Medacta is a pioneer in developing new offerings on the basis of minimally invasive surgical techniques, in particular its Anterior Minimally Invasive Surgery (AMIS) technique for hip replacements. Medacta has leveraged its orthopaedic expertise and comprehensive understanding of the human body to develop the sophisticated MySolutions technology, which offers surgeons highly personalized pre-operative planning and implant placement methodologies by creating advanced personalized kinematic models and 3D planning tools for use in hip, knee, shoulder and spine procedures.